Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics.

Little, Robert D; Ward, Mark G; Wright, Emily; Jois, Asha J; Boussioutas, Alex; Hold, Georgina L; Gibson, Peter R; Sparrow, Miles P

Little, Robert D; Ward, Mark G; Wright, Emily; Jois, Asha J; Boussioutas, Alex; Hold, Georgina L; Gibson, Peter R; Sparrow, Miles P.

Afiliação

Little RD; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
Ward MG; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
Wright E; Department of Gastroenterology, St. Vincent's Hospital, Melbourne University, Melbourne 3004, Australia.
Jois AJ; Department of Gastroenterology & Clinical Nutrition, Royal Children's Hospital, Melbourne 3052, Australia.
Boussioutas A; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
Hold GL; Microbiome Research Centre, St. George Hospital, University of New South Wales, Sydney 2217, Australia.
Gibson PR; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.
Sparrow MP; Department of Gastroenterology, Alfred Health and Monash University, Melbourne 3004, Australia.

J Clin Med ; 11(20)2022 Oct 19.

Article em En | MEDLINE | ID: mdl-36294494

Palavras-chave

CT-P13; infliximab; subcutaneous; therapeutic drug monitoring

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google